|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Costs and expenses: | |||||
| Manufacture and supply | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total costs and expenses | |||||
| Loss from operations | |||||
| Other income (expenses): | |||||
| Interest expense | |||||
| Interest expense related to royalty obligations | |||||
| Interest expense related to the sale of future revenue | |||||
| Interest income and other income, net | |||||
| Loss on the extinguishment of debt | |||||
| Net loss before income taxes | |||||
| Income taxes benefit | |||||
| Net loss | |||||
| Comprehensive loss | |||||
| Loss per share attributable to common stockholders: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...